Aa
vx-500
They are starting the dosing on this compound and it takes me back when they started with vx-950. Is it really possible that this compound will meet or beat the 4+ log drop they had with vx-950? I find it strange that they are already to this stage with a new compound with only a couple of years to market with vx-950. I have tried to get the scoop from vertex but they will say nothen.
Ron
Ron
I'm curious about VX500 too, and the lack of information about it. I guess Vertex are keeping their cards close to their chest until they see what it can or can't do. Great that it's off the starting blocks though.
"VX-500 is a second-generation HCV protease inhibitor. Vertex has initiated dosing in a Phase 1a clinical trial of VX-500. The trial will evaluate single, escalating doses of VX-500 in healthy volunteers. Pending results from the Phase 1a trial, Vertex expects to initiate in mid-2008 a Phase 1b trial of VX-500 in HCV patients."
dointime
"VX-500 is a second-generation HCV protease inhibitor. Vertex has initiated dosing in a Phase 1a clinical trial of VX-500. The trial will evaluate single, escalating doses of VX-500 in healthy volunteers. Pending results from the Phase 1a trial, Vertex expects to initiate in mid-2008 a Phase 1b trial of VX-500 in HCV patients."
dointime
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
